Cleared Traditional

K240366 - EP•XT™ Unidirectional Steerable Diagnostic Catheter

Also marketed or referenced as:
Dynamic Tip™ Unidirectional Steerable Diagnostic Catheter Dynamic XT™ Unidirectional Steerable Diagnostic Catheter

K240366 is an FDA 510(k) clearance for EP•XT Unidirectional Steerable Diagnost..., manufactured by Boston Scientific Corporation. The device is a Class 2 Cardiovascular device with product code DRF cleared through the Traditional 510(k) pathway after a 269-day FDA review.

K240366 · Boston Scientific Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2024
Decision
269d
Days
Class 2
Risk

K240366 is an FDA 510(k) clearance for the EP•XT™ Unidirectional Steerable Diagnostic Catheter. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Boston Scientific Corporation (St Paul, US). The FDA issued a Cleared decision on November 1, 2024 after a review of 269 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Boston Scientific Corporation devices

FDA 510(k) Submission Details - K240366

510(k) Number K240366 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2024
Decision Date November 01, 2024
Days to Decision 269 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
144d slower than avg
Panel avg: 125d · This submission: 269d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRF Device Classification - Class 2, Special Controls

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 140
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K240366.
Vision-MR™ Diagnostic Catheter
K252794 · Imricor Medical Systems, Inc. · Jan 2026
MAGiC Sweep™ EP Mapping Catheter
K250590 · Stereotaxis, Inc. · Jul 2025
VIKING™ Fixed Curve Diagnostic Catheter
K250310 · Boston Scientific Corporation · Jun 2025
Nordica PV Cryo Mapping Catheter
K233900 · Synaptic Medical Corporation · Sep 2024
Cosine-10TM Diagnostic Catheter
K233397 · Medtronic, Inc. · Dec 2023
Polaris X™ Unidirectional Steerable Diagnostic Catheter
K233207 · Boston Scientific Corporation · Oct 2023